ROBIS

Website

 

https://www.bristol.ac.uk/population-health-sciences/projects/robis/

Institution

Main Characteristics

 

University of Bristol

 

ROBIS (Risk Of Bias In Systematic Reviews) is a tool used in the methodological quality assessment of systematic reviews on therapeutic interventions, etiology, diagnostic tests and prognosis. It consists of a 3-stage checklist involving relevance, review process and risk of bias judgment. In the first phase (optional), the user must conclude if the review question meets the objective of the overview or guideline that intends to evaluate the review.  During the second phase, you answer YES, PROBABLY YES, PROBABLY NO, NOT, or NOT INFORMED to each item regarding eligibility criteria, identification and selection of studies, data extraction and critical evaluation of each study, and the synthesis of findings. The third phase involves rating the review according to the risk of bias assessed in phase 2, with the final rating of the risk of bias in HIGH, LOW OR UNCLEAR.
ROBIS – Key Publications

 

Whiting P, Savović J, Higgins JPT, Caldwell DM, Reeves BC, Shea B, et al. ROBIS: A new tool to assess risk of bias in systematic reviews was

developed. J Clin Epidemiol. 2016;

 

Banzi R, Cinquini M, Gonzalez-Lorenzo M, Pecoraro V, Capobussi M, Minozzi S. Quality assessment versus risk of bias in systematic reviews: AMSTAR

and ROBIS had similar reliability but differed in their construct and applicability. J Clin Epidemiol. 2018;

 

Whiting P, Svovic J, Higgins J, Caldwell D, Reeves B, Shea B, et al. ROBIS : Tool to assess risk of bias in systematic reviews Guidance on how to use

ROBIS. Univ Bristol Sch Soc Community Med. 2018;

 

Pieper D, Puljak L, González-Lorenzo M, Minozzi S. Minor differences were found between AMSTAR 2 and ROBIS in the assessment of systematic

reviews including both randomized and nonrandomized studies. J Clin Epidemiol. 2019;

 

 


 

ROBIS

Página na Internet

 

https://www.bristol.ac.uk/population-health-sciences/projects/robis/

Instituição

Características Principais

 

Universidade de Bristol

 

O ROBIS (Risk Of Bias In Systematic Reviews) é uma ferramenta utilizada na avaliação da qualidade metodológica de revisões sistemáticas sobre intervenções terapêuticas, etiologia, testes diagnósticos e prognóstico. Consiste em um checklist com 3 fases envolvendo a relevância, o processo de revisão e o julgamento de risco de viés. Na primeira fase, o usuário deve concluir se a pergunta da revisão atende ao objetivo do overview ou do guideline que pretende avaliar a revisão.  Durante a segunda fase, o usuário responde SIM, PROVAVELMENTE SIM, PROVAVELMENTE NÃO, NÃO ou NÃO INFORMADO a cada item referente à critérios de elegibilidade, identificação e seleção de estudos, extração de dados e avaliação crítica de cada estudo, e a síntese dos achados. A terceira fase envolve a classificação da revisão de acordo com o risco de viés avaliado na fase 2, com a classificação final do risco de viés da revisão em ALTO, BAIXO OU INCERTO.
ROBIS – Principais publicações

 

Whiting P, Savović J, Higgins JPT, Caldwell DM, Reeves BC, Shea B, et al. ROBIS: A new tool to assess risk of bias in systematic reviews was

developed. J Clin Epidemiol. 2016;

 

Banzi R, Cinquini M, Gonzalez-Lorenzo M, Pecoraro V, Capobussi M, Minozzi S. Quality assessment versus risk of bias in systematic reviews: AMSTAR

and ROBIS had similar reliability but differed in their construct and applicability. J Clin Epidemiol. 2018;

 

Whiting P, Svovic J, Higgins J, Caldwell D, Reeves B, Shea B, et al. ROBIS : Tool to assess risk of bias in systematic reviews Guidance on how to use

ROBIS. Univ Bristol Sch Soc Community Med. 2018;

 

Pieper D, Puljak L, González-Lorenzo M, Minozzi S. Minor differences were found between AMSTAR 2 and ROBIS in the assessment of systematic

reviews including both randomized and nonrandomized studies. J Clin Epidemiol. 2019;